Hamilton Eye Institute at University of Tennessee

Memphis, Tennessee 38163

0 studies enrolling now · 1 studies all time

What they study most

Thyroid Associated Ophthalmopathies, Thyroid-Associated Ophthalmopathy

Studies at this site

• Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease — Completed